Skip to content

Author

S. Garcia Borrego

We have 1 of 3 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

KRASG12V Degraders Provide a Potential Therapeutic Opportunity in Lung Adenocarcinoma.

PERTACs that degrade the KRAS oncoprotein are a promising modality for the treatment of lung adenocarcinomas, and resistance to PROTACs may differ from conventional KRAS inhibitors, suggesting potential strategies for overcoming such resistance.

S. Garcia Borrego, S. Misale · 0 citations